KY19382, a promising compound for hair loss, is not widely discussed or used. One user is currently testing it and plans to share results in a few weeks.
Clascoterone showed promising initial results for hair regrowth but failed to replicate them, leading to disappointment. Users discuss combining it with minoxidil and other treatments, noting its current availability only in lower concentrations.
The user has been using Him's chewable finasteride (1.2mg) and minoxidil (3mg) for six months and has seen some hair regrowth but is considering switching to dutasteride. Others advise patience, suggesting that significant results often take 12 to 18 months, and recommend sticking with the current treatment longer before making changes.
The user experienced hair loss issues after switching from finasteride to dutasteride and back, with stress and seborrheic dermatitis affecting hair quality. They plan to continue finasteride, treat seborrheic dermatitis, and monitor nutrient levels, considering low-dose oral minoxidil if safe.
A user shared their 6-month progress using finasteride for hair loss, reporting significant improvement without side effects. They previously used saw palmetto and currently take omega-3, curcumin, and vitamin D supplements.
A 35-year-old man is considering adjusting his hair loss treatment, currently using 0.5 mg dutasteride and 5% topical minoxidil, with inconsistent application. He is advised to add oral minoxidil for consistency and possibly increase the dutasteride dosage while continuing Ayurvedic treatments for hair texture.
ABS-201 shows promise for male hair regrowth by blocking the prolactin receptor, with higher expected efficacy than current treatments. The discussion also covers dosing differences between macaques and humans for hmi115, highlighting a significant dosage disparity.
A trans man experiencing hair loss after starting testosterone treatment has seen positive results using topical minoxidil and finasteride, though his hair remains thin. He is considering continuing his current treatment and exploring additional options like microneedling and Breezula, while acknowledging the impact of testosterone on hair loss.
The conversation discusses the potential for developing a biologic "DHT sponge" to neutralize DHT in the bloodstream as a treatment for hair loss, suggesting it could be more targeted and have fewer side effects than current treatments like finasteride and dutasteride. Concerns include the complexity, cost, and potential side effects of such a treatment, as well as skepticism about its feasibility and market interest.
A user shared their positive experience using finasteride and minoxidil at 36, after having unpleasant side effects at 18. They report no current side effects and are seeing good progress with their hair, including using microneedling weekly.
A user is considering switching to a topical treatment containing finasteride, minoxidil, and tretinoin, instead of their current regimen of oral finasteride and oral minoxidil. They are unsure whether to try the new topical or continue with their current treatment.
Breezula's phase 3 results are expected soon, but its release is likely delayed until 2027 or 2028. The discussion highlights the need for more hair growth stimulants like AMP-303 and PP-405, as current treatments like Dutasteride effectively stop hair loss but don't regrow hair.
The user experienced significant hair regrowth after 3 months using topical minoxidil 5% and oral finasteride, with initial shedding but no lasting side effects. They considered adding microneedling but were advised against it, as their current treatment was already effective.
Stopping finasteride due to side effects and family planning can lead to temporary increased hair shedding, which may stabilize over time. Consider topical treatments or a lower dose after addressing current concerns.
A user has been using 1mg oral finasteride and 5% topical minoxidil for six months, with some derma stamping, but feels hair growth has stagnated and is considering PRP or a hair transplant. Others advise continuing the current regimen, noting that maintaining existing hair is an achievement, and suggest ignoring negative comments from friends.
The user has been using topical minoxidil and oral finasteride for hair regrowth, noticing some improvement and baby hairs at the hairline after four months. Suggestions include continuing the current treatment, considering microneedling, ketoconazole shampoo, vitamins, and possibly RU58841, while avoiding a hair transplant.
A 26-year-old male experienced hair thinning since age 18 and tried various treatments, including topical minoxidil, oral finasteride, and a hair transplant. He is currently using topical finasteride, minoxidil, tretinoin, hydrocortisone, and oral dutasteride, and is satisfied with the results 6.5 months post-transplant.
A 22-year-old shared their hair loss journey, starting with homeopathic treatments and later using Minoxidil and Finasteride, seeing some regrowth. They are currently on oral Finasteride, PRP treatments, and saw palmetto serum, considering reintroducing Minoxidil or switching to Dutasteride for better results.
The user is considering adding liposomal dutasteride to their hair loss treatment, which currently includes topical finasteride and minoxidil. They are exploring different concentrations and application frequencies to enhance hair retention and are also planning to continue using Rogaine.
The user is experiencing hair loss despite using 0.5 mg dutasteride and 2.5 mg oral minoxidil daily. They are considering increasing the dutasteride dosage or maintaining the current routine.
The conversation is about managing hair loss while on hormone replacement therapy (HRT) with estrogen and spironolactone. The user considers adding finasteride but decides to wait and see the effects of the current treatment.
The user experienced worsening hair density despite using finasteride, minoxidil, dutasteride, and RU58841, with some temporary improvement after stopping RU58841. Currently, they are on 2.5mg dutasteride daily and topical minoxidil, but continue to struggle with hair density issues.
The user shared progress pictures showing significant hair regrowth after 8 months using finasteride and Minoxidil foam. They have not used microneedling and are considering oral Minoxidil but currently use topical Minoxidil and oral finasteride.
A 29-year-old male experienced hair regrowth using minoxidil 5% foam and KX826 after stopping finasteride due to side effects. He applies both treatments once daily and reports no side effects from the current regimen.
A user on finasteride for 7 months is experiencing increased hair loss and is considering adding dutasteride or minoxidil to their regimen. They are seeking advice on whether to switch treatments or continue their current plan.
A 17-year-old is considering using saw palmetto for hair loss until they can get finasteride, while currently using minoxidil and ketoconazole. Users suggest that saw palmetto is weak, and recommend continuing minoxidil and ketoconazole until finasteride is available.
The conversation discusses the potential of using topical estrogen treatments for hair loss without systemic absorption, highlighting challenges and possible solutions like using estriol. It also mentions other treatments like topical finasteride, microneedling, and scalp massage, while noting the limitations and side effects of current options.
Exploring future hair loss treatments, including immunosuppressants for hair transplants and hair cloning, with a focus on leveraging research from other medical fields. Current treatments like finasteride and minoxidil are effective for most, but there's a call for more funding and innovation in the hair loss industry.
Switching from minoxidil foam to topical solution and considering adding caffeine, melatonin, or cetirizine. Currently using 2.5mg oral minoxidil and 1mg oral finasteride, planning to ask for 0.5mg oral dutasteride and 5mg oral minoxidil.
The conversation is about future hair loss treatments. Current treatments mentioned include finasteride, minoxidil, and RU58841, with potential future treatments like GT20029, TDM-105795, JW0061, and follicle cloning.